Navigation Links
$2.5 Million Gift Aims to Help Children Survive and Thrive
Date:3/24/2010

Dr. David Wessel Named IKARIA® Distinguished Professor of Critical Care Medicine at Children’s National Medical Center

Washington, DC (Vocus) March 24, 2010 -- On Tuesday Children’s National Medical Center appointed David L. Wessel, MD, as the first IKARIA® Distinguished Professor of Critical Care Medicine. Dr. Wessel is the division chief and senior vice president of hospital-based specialties and is internationally known for his pioneering work in caring for infants with heart disease.

The $2.5 million endowment was created by IKARIA, a biotherapeutics company whose acute care products and therapies address the significant unmet needs of critically ill patients.

“The dedication of the health care professionals who work in the critical care environment is our constant inspiration,” said Daniel Tassé, chairman and chief executive officer of IKARIA. “Caring for critically ill patients demands commitment, passion and perseverance, and we are honored to have the opportunity to recognize the outstanding work of Dr. David Wessel, who has demonstrated extraordinary achievement in this area.”

Edwin K. Zechman Jr., president and CEO of Children’s National, said, “We are grateful for IKARIA’s generosity and commitment to improving the care of our most vulnerable patients. This partnership will be life-changing – and life-saving – for so many.”

Dr. Wessel said, “We are convinced that refining critical care treatments will improve long-term physical and developmental outcomes for our young patients. At Children’s National Medical Center, our goal is for children to not only survive, but thrive.”

Educated and trained in medicine at Oxford, Yale and Harvard, Dr. Wessel joined Children’s National Medical Center in July 2007. Prior to joining Children’s National he was professor of pediatrics at Harvard Medical School and senior associate in cardiology and anesthesia at Children’s Hospital Boston. He is board certified in anesthesiology, pediatrics, pediatric cardiology and pediatric critical care medicine.

An experienced scientist and clinical researcher with over 100 peer-reviewed publications, Dr. Wessel has made seminal contributions to the field of critical care medicine. Widely viewed as the “father of pediatric cardiac intensive care,” he has trained a vast number of practicing clinical leaders in the field. Dr. Wessel has also been listed as one of the “Best Doctors in America” continuously since the inception of the ranking.

Dr. Wessel is married and has four children.

Contact Stacy Williams, 301-565-8523, stwillia(at)cnmc(dot)org

About Children’s National Medical Center
Children's National Medical Center, located in Washington, DC, is a proven leader in the development of innovative new treatments for childhood illness and injury. Children’s has been serving the nation's children for more than 135 years. Children’s National is ranked among the best pediatric hospitals in America by US News & World Report and the Leapfrog Group. For more information, visit www.ChildrensNational.org.

About IKARIA Holdings, Inc.
Ikaria Holdings, Inc. is a biotherapeutics company whose acute care products and therapies address the significant unmet needs of critically ill patients. The company’s lead product, INOMAX® (nitric oxide) for inhalation, is the only FDA-approved drug for the treatment of hypoxic respiratory failure in term and near-term newborns, and also is marketed in Canada, Europe, Latin America, Australia, Japan and Mexico. Ikaria is engaged in new and ongoing clinical development of INOMAX and hydrogen sulfide. Ikaria acquired the North American rights to terlipressin, a potential treatment for hepatorenal syndrome Type 1, as well as the exclusive worldwide licenses to BL-1040, a potential breakthrough treatment for preventing pathological cardiac remodeling following acute myocardial infarction, and to a portfolio of investigational compounds focused on vascular leakage for a range of critical care conditions, such as acute lung and kidney injury. Ikaria is headquartered in Clinton, N.J., with research facilities in Seattle, Wash., and Madison, Wisc., and a manufacturing facility in Port Allen, La. For more information, visit www.ikaria.com.

###

Read the full story at http://www.prweb.com/releases/childrens-national/IKARIA-Holdings/prweb3773644.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. GSK Joins Global Vaccine Alliance to Help Prevent Millions of Children from Contracting Pneumococcal Disease in the Worlds Poorest Countries
2. New York College of Osteopathic Medicine (NYCOM) at NYIT Awarded $1 Million Federal Grant
3. Wireless LAN Innovator Aerohive Secures $23.5 Million Series C Investment
4. Bloomberg School of Public Health awarded $15 million for laboratory renovation and modernization
5. Massage Envy Performs 20 Millionth Massage
6. PROLOR Biotech Announces Sale of $24.4 Million of Common Stock
7. National Center for Policy Analysis and Salem Radio Network Deliver One Million Emails to Congress to Stop ObamaCare
8. Democracy on Trial: SEIUs $25 Million Lawsuit Against Union Reformers Goes to Court Monday
9. 27th Annual Shamrocks Against Dystrophy Sets $20 Million Fundraising Record
10. Non-Melanoma Skin Cancers in the Millions and Rising
11. Online Medical Supplies Superstore Ships 1 Millionth Order
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
$2.5 Million Gift Aims to Help Children Survive and Thrive
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional ... action towards gender equality at their inaugural Summit in New York City in June. ... a social audience of over 3 million. To watch the Mobilize Women video, ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... 2017 , ... Dr. Parsa Mohebi, the Los Angeles based ... the newly revamped Cosmetic Town journal section, featuring articles written by ... as Follicular Unit Extraction (FUE). , Dr. Mohebi says “I enjoy ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy ... health literacy software tool, and the Cancer Patient Education Network (CPEN), an independent ... today announce a new strategic alliance. , As CPEN’s strategic partner, HLI ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... -- AVACEN Medical , Inc. (AVACEN) announced that Frost ... Product Innovation Award for Its fibromyalgia pain management device. ... device market research by Frost & Sullivan,s industry experts. ... relief product, the AVACEN 100, offers a safe and effective ... ...
(Date:10/11/2017)...  BioPharmX Corporation (NYSE MKT: BPMX) researchers were part ... way to use nonlinear optical imaging to confirm the ... A presentation ... how researchers from BioPharmX and the Wellman Center for ... suite of imaging techniques in what is called "Pharmacokinetic ...
(Date:10/11/2017)... Oct. 11, 2017  Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: ... facility in Las Piedras, Puerto Rico ... blades. Following ... facility sustained minor structural damage, temporary loss of power ... have been completed, manufacturing operations have resumed, and the ...
Breaking Medicine Technology: